Cargando…

Oncogenic driver mutations in Swiss never smoker patients with lung adenocarcinoma and correlation with clinicopathologic characteristics and outcome

PURPOSE: Lung cancer in never smokers is recognized as a distinct molecular, clinicopathologic and epidemiologic entity. The aim of the study was to investigate the molecular profile in Swiss never smokers with lung adenocarcinoma and to correlate the mutation status with clinicopathologic and demog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grosse, Claudia, Soltermann, Alex, Rechsteiner, Markus, Grosse, Alexandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684066/ https://www.ncbi.nlm.nih.gov/pubmed/31386689 http://dx.doi.org/10.1371/journal.pone.0220691

Ejemplares similares

Analysis of the frequency of oncogenic driver mutations and correlation with clinicopathological characteristics in patients with lung adenocarcinoma from Northeastern Switzerland
por: Grosse, Alexandra, et al.
Publicado: (2019)

Spectrum of Oncogenic Driver Mutations in Lung Adenocarcinomas from East Asian Never Smokers
por: Li, Chenguang, et al.
Publicado: (2011)

Common Oncogene Mutations and Novel SND1-BRAF Transcript Fusion in Lung Adenocarcinoma from Never Smokers
por: Jang, Jin Sung, et al.
Publicado: (2015)

Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma
por: Mack, Philip C, et al.
Publicado: (2022)

Genomic Aberrations in Lung Adenocarcinoma in Never Smokers
por: Job, Bastien, et al.
Publicado: (2010)

Conserved recurrent gene mutations correlate with pathway deregulation and clinical outcomes of lung adenocarcinoma in never-smokers
por: Sun, Zhifu, et al.
Publicado: (2014)

Distinct immune microenvironment of lung adenocarcinoma in never-smokers from smokers
por: Luo, Wenxin, et al.
Publicado: (2023)

Differences in EGFR and KRAS mutation spectra in lung adenocarcinoma of never and heavy smokers
por: TAKAMOCHI, KAZUYA, et al.
Publicado: (2013)

Erratum to: Conserved recurrent gene mutations correlate with pathway deregulation and clinical outcomes of lung adenocarcinoma in never-smokers
por: Sun, Zhifu, et al.
Publicado: (2017)

Intratumoral Heterogeneity and Immune Modulation in Lung Adenocarcinoma in Female Smokers and Never Smokers
por: Trefzer, Timo B., et al.
Publicado: (2022)

287 Genomic and Immunologic Characterization of Lung Adenocarcinoma in Never Smokers vs. Smokers
por: Li, P. Jonathan, et al.
Publicado: (2023)

Lung cancer in never-smoker Asian females is driven by oncogenic mutations, most often involving EGFR
por: Ha, Sang Yun, et al.
Publicado: (2015)

Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers
por: Ahn, Jin Woo, et al.
Publicado: (2014)

Synchronous Primary Lung Cancers Containing Discrete Driver Mutations in a Never-Smoker: Case Report
por: Davis, Andrew, et al.
Publicado: (2023)

Common driver mutations and programmed death-ligand 1 expression in advanced non-small cell lung cancer in smokers and never smokers
por: LIAM, Chong Kin, et al.
Publicado: (2023)

Characteristics of genomic alterations of lung adenocarcinoma in young never‐smokers
por: Luo, Wenxin, et al.
Publicado: (2018)

Former smokers with non‐small‐cell lung cancers: a comprehensive investigation of clinicopathologic characteristics, oncogenic drivers, and prognosis
por: Zheng, Shanbo, et al.
Publicado: (2016)

Chinese never smokers with adenocarcinoma of the lung are younger and have fewer lymph node metastases than smokers
por: Shan, Longyu, et al.
Publicado: (2022)

Major Oncogenic Drivers and Their Clinicopathological Correlations in Sporadic Childhood Papillary Thyroid Carcinoma in Belarus
por: Rogounovitch, Tatiana I., et al.
Publicado: (2021)

Prevalence and correlates of airflow obstruction in ∼317 000 never-smokers in China
por: Smith, Margaret, et al.
Publicado: (2014)

Genetic differences between smokers and never-smokers with lung cancer
por: Kuśnierczyk, Piotr
Publicado: (2023)

Addiction to the nicotine gum in never smokers
por: Etter, Jean-François
Publicado: (2007)

Never-smoker African–American women suffer more from COPD compared with never-smoker Caucasian women
por: Sumon, Mahbubur, et al.
Publicado: (2020)

Lung Adenocarcinoma of Never Smokers and Smokers Harbor Differential Regions of Genetic Alteration and Exhibit Different Levels of Genomic Instability
por: Thu, Kelsie L., et al.
Publicado: (2012)

Deep sequencing of the microRNA transcriptome in current, former, and never smokers with lung adenocarcinoma
por: Wang, Teresa W, et al.
Publicado: (2012)

A High-Dimensional, Deep-Sequencing Study of Lung Adenocarcinoma in Female Never-Smokers
por: Kim, Sang Cheol, et al.
Publicado: (2013)

DNA methylation is associated with lung function in never smokers
por: de Vries, Maaike, et al.
Publicado: (2019)

AGER expression and alternative splicing in bronchial biopsies of smokers and never smokers
por: Faiz, Alen, et al.
Publicado: (2019)

Descriptive characteristics of hospitalized adult smokers and never-smokers with COVID-19
por: Kalan, Mohammad Ebrahimi, et al.
Publicado: (2020)

Are Complication Rates of Breast Reduction Similar in Former Smokers and Never Smokers?
por: Cruz, Norma
Publicado: (2021)

TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer Patients
por: Halvorsen, Ann R., et al.
Publicado: (2016)

Analysis of Fifty Hotspot Mutations of Lung Squamous Cell Carcinoma in Never-smokers
por: Lee, Ha Youn, et al.
Publicado: (2017)

Tumor Mutational Burden by Whole-Genome Sequencing in Resected NSCLC of Never Smokers
por: Ruel, Louis-Jacques, et al.
Publicado: (2022)

Serum Cotinine Levels and Prehypertension in Never Smokers
por: Alshaarawy, Omayma, et al.
Publicado: (2013)

Molecular profile of lung cancer in never smokers
por: Subramanian, Janakiraman, et al.
Publicado: (2013)

Small-cell lung cancer in never-smokers
por: Torres-Durán, M., et al.
Publicado: (2021)

Epigenetic modelling of former, current and never smokers
por: Langdon, Ryan J., et al.
Publicado: (2021)

Oncogenic driver mutations in lung cancer
por: Luo, Susan Y, et al.
Publicado: (2013)

RARβ2 hypermethylation is associated with poor recurrence-free survival in never-smokers with adenocarcinoma of the lung
por: Kim, Yujin, et al.
Publicado: (2015)

Comprehensive Profiling of lincRNAs in Lung Adenocarcinoma of Never Smokers Reveals Their Roles in Cancer Development and Prognosis
por: Li, Ying, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0ofsnci7kdks4j52rh9e4il40p